
Cardiovascular risk factors play greater role in adverse outcomes in thymic cancer patients
Thymic cancer, a rare type of cancer that has brought patients to Indiana University Health in recent years for treatment, has become the subject of further study between investigators from the Krannert Cardiovascular Research Center and the Melvin and Bren Simon Comprehensive Cancer Center at Indiana University School of Medicine, and collaborators at Regenstrief Institute. The researchers wanted to explore cardiovascular risk factors for adverse outcomes among people with and without thymic cancer. Results of their study was published in Frontiers.

Black patients play key role in advancing breast cancer research
Community advocates are partnering with Indiana University School of Medicine to spread the word about the importance of including Black women in clinical research for

New Neurosurgeon-Scientists Strengthen Scope of Care and Neuroscience Research
The IU School of Medicine Department of Neurological Surgery continues to the broaden its scope in providing world-class clinical care and research with the addition of

'Whac-a-Mole' clinical trial participant experiences remission of Stage 4 triple negative breast cancer
Jenny Larner Brown dreams of a day when no one would ever hear their oncologist say, "We're out of options." It's now been more than

Chuckstrong Backyard Huddle raises nearly $2.5 million for cancer research
In a night that brought together cancer survivors, researchers and philanthropists, the Chuckstrong Backyard Huddle raised nearly than $2.5 million July 29 for cancer research

Precision Health pediatric sarcomas researchers share updates and goals with golfers at inaugural Tyler Trent charity outing
More than 140 golfers participated in the inaugural Tyler Trent Foundation “Tee Off for Tyler” Charity Golf Classic at the Bridgewater Club in Carmel. The

IU School of Medicine faculty providing comprehensive care for hereditary cancers at IU Simon Comprehensive Cancer Center
In 2018, urologic oncologist Ronald Boris, MD, MS, geneticist Gail Vance, MD and genitourinary medical oncologist Nabil Adra, MD established a multidisciplinary clinic focused on

Larry Einhorn, MD, answers questions about testicular cancer
April is Testicular Cancer Awareness Month. Testicular cancer, though rare, is a cancer that primarily affects young men. It also differs from other forms of

Indiana Myeloma Registry tracks individual patient journeys, data in search of a cure
Hoosiers with multiple myeloma can provide important data to researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center who are searching for a

Dr. Koch answers questions about prostate cancer
Michael Koch, M.D., chair of the IU School of Medicine’s Department of Urology and a member of the IU Simon Comprehensive Cancer Center, is a

HPV expert Darron Brown, MD, discusses the vaccine’s dramatic impact on reducing cervical cancer
A recent, new study published in the New England Journal of Medicine — which has been hailed as a “milestone” study — confirmed that widespread